Emma Walmsley
Chief Executive Officer at GlaxoSmithKline
Meet Emma Walmsley
Walmsley first joined GSK in 2010, initially working for the Consumer Healthcare, Europe, division. She became CEO in April 2017. The company missed a key internal profit goal in 2020 due to the impact of the pandemic, but still performed well. Recently, the company announced promising results from a phase III trial with Vir Biotechnology for a monoclonal antibody to treat COVID-19.